India close to rolling out weight-loss drug Tirzepatide: How does it work? | Vantage with Palki Sharma
The wait for India’s weight watchers is almost over. Weight loss drugs will soon make its debut in the Indian markets. Last week, India's apex drug regulator gave the green light to Eli Lilly’s tirzepatide — the active ingredient in the company’s Mounjaro and Zepbound. How does it work? What are the side-effects? Palki Sharma tells you.
---
India | Weight-Loss Drug | Tirzepatide | Eli Lilly | Mounjaro | Zepbound | Firstpost | World News | Vantage | Palki Sharma
#india #weightlossdrug #tirzepatide #firstpost #vantageonfirstpost #palkisharma #worldnews
Vantage is a ground-breaking news, opinions, and current affairs show from Firstpost. Catering to a global audience, Vantage covers the biggest news stories from a 360-degree perspective, giving viewers a chance to assess the impact of world events through a uniquely Indian lens.
The show is anchored by Palki Sharma, Managing Editor, Firstpost.
By breaking stereotypes, Vantage aims to challenge conventional wisdom and present an alternative view on global affairs, defying the norm and opening the door to new perspectives. The show goes beyond the headlines to uncover the hidden stories – making Vantage a destination for thought-provoking ideas.
Vantage airs Monday to Friday at 9 PM IST on Firstpost across all leading platforms.
Subscribe to Firstpost channel and press the bell icon to get notified when we go live.
[ Ссылка ]
Follow Firstpost on Instagram:
[ Ссылка ]
Follow Firstpost on Facebook:
[ Ссылка ]
Follow Firstpost on Twitter:
[ Ссылка ]
Follow Firstpost on WhatsApp:
[ Ссылка ]
